TOG Review (RCOG Journal)
MRCOG Part 2
Maternal Medicine
Diagnosis and management of liver masses in pregnancy
Key Statistics
- ~20% — General population with benign liver lesion
- 27.2% — Lifetime haemorrhage risk, hepatic adenoma
- 44% / 38% — Maternal / fetal mortality, HA rupture
Don't-miss facts
-
Any acutely shocked pregnant patient with severe epigastric pain radiating to the back – consider occult liver mass rupture once other obstetric causes excluded
-
Hepatic adenoma: lifetime haemorrhage risk 27.2%, rupture rate 15.8%; risk highest in 3rd trimester and with lesions
10 cm
-
Acute hepatic haemorrhage – hepatic artery embolisation is first-line, before emergency surgery/liver packing/resection
-
HA malignant transformation risk 4.2–10% (4.4% if <5 cm) – elective resection threshold is >5 cm
-
Liver biopsy not routinely used for suspected adenoma (bleeding/seeding risk); dynamic gadolinium MRI is diagnostic first step
-
CT liver protocol fetal dose 1–10 mGy (childhood cancer risk 1/10,000–1/100,000); MRI with gadolinium preferred in pregnancy
-
Postpartum falling hormones can trigger HA degeneration/haemorrhage – the high-risk period does not end at delivery; advise against future OCP/anabolic steroids
-
No evidence favouring early induction or caesarean over vaginal delivery for haemangioma or FNH; vaginal delivery reported safe even with known HA
Benign vs malignant at a glance
Benign: haemangioma (commonest), FNH (2nd commonest, no malignant potential), hepatic adenoma (highest bleed risk)
Malignant: hepatocellular carcinoma, cholangiocarcinoma, metastases
Abbreviation Key
- FNH — focal nodular hyperplasia
- PET-CT — positron-emission tomography–CT
- HA — hepatic adenoma
- AFP — alphafetoprotein
- HCC — hepatocellular carcinoma
- HELLP — haemolysis, elevated liver enzymes, low platelets
- OCP — oral contraceptive pill PALM
- study — Pregnancy And Liver adenoma Management study
- CT — computed tomography
- MDT — multidisciplinary team
- MRI — magnetic resonance imaging
Source: Diagnosis and management of liver masses in pregnancy. The Obstetrician & Gynaecologist 2016;18:43–51. doi:10.1111/tog.12260
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).